Inventor · disambiguated record
Steven Josephs
Also filed as: JOSEPHS STEVEN · JOSEPHS STEVEN F · JOSEPHS STEVEN FRANCIS
9 granted patents·25 pending applications·15 citations·filing 1995–2024
81Inventor score
Top patents by PatentIndex Score
34 records- 0185US2024034797A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2023·Application pending·0 cites
- 0282USRE38824EAntibodies against human herpes virus-6(HHV-6) and method of useUS HEALTH·Filed 2002·Granted Oct 11, 2005·10 cites·12 claims
- 0376US2022288294A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 0476US2022249363A1Augmentation of personalized tumor specific adaptive immunity through extracorporeal removal of immune blocking factorsIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 0575US11814430B2Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Granted Nov 14, 2023·0 cites·11 claims
- 0674US11458236B2Reduced leaching of a ligandIMMUNICOM INC·Filed 2021·Granted Oct 4, 2022·0 cites·20 claims
- 0774US2022054726A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 0874US2022041730A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 0974US2022041729A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1074US2022054727A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1174US2022054725A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1274US2022041732A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1374US2022041731A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1473US2022265913A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 1573US2022040087A1Augmentation of personalized tumor specific adaptive immunity through extracorporeal removal of immune blocking factorsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1673US2022054728A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1773US2022040088A1Augmentation of personalized tumor specific adaptive immunity through extracorporeal removal of immune blocking factorsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1872US2021198362A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1971US11224858B1Reduced leaching of a ligandIMMUNICOM INC·Filed 2021·Granted Jan 18, 2022·0 cites·10 claims
- 2070US11123467B2System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2020·Granted Sep 21, 2021·0 cites·14 claims
- 2169US2022126272A1Reduced leaching of a ligandIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 2268US2021146029A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2019·Application pending·0 cites
- 2367US2009285903A1Methods for dendritic cell therapy using pharmacologically active microcarriersTHENNJECT LLC·Filed 2009·Application pending·0 cites
- 2466US2009259160A1System and composition for dendritic cell therapy using pharmacologically active microcarriersTHERINJECT LLC·Filed 2009·Application pending·0 cites
- 2565US2018243208A1Augmentation of personalized tumor specific adaptive immunity through extracorporeal removal of immune blocking factorsIMMUNICOM INC·Filed 2018·Application pending·0 cites
- 2664US2023137154A1Reduced leaching of a ligandIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 2763US2024252732A1Modified tnf as a capture ligandIMMUNICOM INC·Filed 2024·Application pending·0 cites
- 2861US11957825B2Modified TNF as a capture ligandIMMUNICOM INC·Filed 2022·Granted Apr 16, 2024·0 cites·21 claims
- 2942US2018153984A1Adjuvant particles comprising adenosine receptor antagonistsUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 3041US2004208846A1Mini-Ad vector for immunizationFiled 2004·Application pending·0 cites
- 3137US6054283AAntibodies against human herpesvirus-6(HHV-6) and method of useUS HEALTH·Filed 1996·Granted Apr 25, 2000·5 cites·3 claims
- 3236US2003192066A1Minimal adenoviral vectorGENSTAR THERAPEUTICS CORP·Filed 2002·Application pending·0 cites
- 3331US5604093AHuman herpesvirus-6(HHV-6)Isolution and ProductsUS HEALTH·Filed 1995·Granted Feb 18, 1997·0 cites·8 claims
- 3430US6018027AHuman herpesvirus-6 (HHV-6) isolation and productsUS HEALTH·Filed 1997·Granted Jan 25, 2000·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Steven Josephs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →